MENU
last data update: 2011/10/14, 09:39
Website loading time
during the test: 0.74 s
cable connection (average): 0.77 s
DSL connection (average): 0.81 s
modem (average): 2.56 s
HTTP headers
HTTP/1.1 200 OK
Cache-Control: private
Content-Length: 13061
Content-Type: text/html
X-Powered-By: ASP.NET
Set-Cookie: ASPSESSIONIDCSBRBQQA=DBFBCMCAJFNCBPGMKMMKNMGK; path=/
Server: Apache
Date: Fri, 14 Oct 2011 16:43:43 GMT
Connection: close
Information about DNS servers
elan.com | TXT | 1CY3OGng4wt3qwhUAwRik/BjVM4Ve8nLp4GISJvgRDXyHOKED5eo5+TUZeaCh/0U/lu2utcBrFh8Z37dcUnA1w== | Array | IN | 14400 |
elan.com | TXT | v=spf1 include:outlook.com ~all | Array | IN | 14400 |
elan.com | A | 65.79.177.80 | IN | 900 | |
elan.com | MX | 4 | tems2b.ironmountain.com | IN | 14400 |
elan.com | MX | 6 | ms77853124.void.mail.eo.outlook.com | IN | 14400 |
elan.com | MX | 2 | tems2a.ironmountain.com | IN | 14400 |
elan.com | SOA | dns1.idp365.net | postmaster.safenames.net | 2011081802 | 28800 1800 604800 300 IN 14400 |
elan.com | NS | dns2.idp365.net | IN | 14400 | |
elan.com | NS | dns1.idp365.net | IN | 14400 | |
elan.com | NS | dns3.idp365.net | IN | 14400 |
Received from the first DNS server
Request to the server "elan.com"
You used the following DNS server:
DNS Name: dns2.idp365.net
DNS Server Address: 109.234.198.10#53
DNS server aliases:
HEADER opcode: REQUEST, status: NOERROR, id: 37121
flag: qr aa rd REQUEST: 1, ANSWER: 10, AUTHORITY: 0, ADDITIONAL: 3
REQUEST SECTION:
elan.com. IN ANY
ANSWER SECTION:
elan.com. 14400 IN SOA dns1.idp365.net. postmaster.safenames.net. 2011081802 28800 1800 604800 300
elan.com. 14400 IN MX 4 tems2b.ironmountain.com.
elan.com. 14400 IN MX 6 ms77853124.void.mail.eo.outlook.com.
elan.com. 14400 IN MX 2 tems2a.ironmountain.com.
elan.com. 14400 IN NS dns1.idp365.net.
elan.com. 14400 IN NS dns2.idp365.net.
elan.com. 14400 IN NS dns3.idp365.net.
elan.com. 900 IN A 65.79.177.80
elan.com. 14400 IN TXT "1CY3OGng4wt3qwhUAwRik/BjVM4Ve8nLp4GISJvgRDXyHOKED5eo5+TUZeaCh/0U/lu2utcBrFh8Z37dcUnA1w=="
elan.com. 14400 IN TXT "v=spf1 include:outlook.com ~all"
SECTION NOTES:
dns1.idp365.net. 86400 IN A 217.19.248.20
dns2.idp365.net. 86400 IN A 109.234.198.10
dns3.idp365.net. 86400 IN A 207.228.239.80
Received 466 bytes from address 109.234.198.10#53 in 78 ms
Received from the second DNS server
Request to the server "elan.com"
You used the following DNS server:
DNS Name: dns1.idp365.net
DNS Server Address: 217.19.248.20#53
DNS server aliases:
HEADER opcode: REQUEST, status: NOERROR, id: 6383
flag: qr aa rd REQUEST: 1, ANSWER: 10, AUTHORITY: 0, ADDITIONAL: 3
REQUEST SECTION:
elan.com. IN ANY
ANSWER SECTION:
elan.com. 14400 IN TXT "1CY3OGng4wt3qwhUAwRik/BjVM4Ve8nLp4GISJvgRDXyHOKED5eo5+TUZeaCh/0U/lu2utcBrFh8Z37dcUnA1w=="
elan.com. 14400 IN TXT "v=spf1 include:outlook.com ~all"
elan.com. 900 IN A 65.79.177.80
elan.com. 14400 IN SOA dns1.idp365.net. postmaster.safenames.net. 2011081802 28800 1800 604800 300
elan.com. 14400 IN NS dns1.idp365.net.
elan.com. 14400 IN NS dns2.idp365.net.
elan.com. 14400 IN NS dns3.idp365.net.
elan.com. 14400 IN MX 6 ms77853124.void.mail.eo.outlook.com.
elan.com. 14400 IN MX 2 tems2a.ironmountain.com.
elan.com. 14400 IN MX 4 tems2b.ironmountain.com.
SECTION NOTES:
dns1.idp365.net. 86400 IN A 217.19.248.20
dns2.idp365.net. 86400 IN A 109.234.198.10
dns3.idp365.net. 86400 IN A 207.228.239.80
Received 466 bytes from address 217.19.248.20#53 in 77 ms
Subdomains (the first 50)
Typos (misspells)
wlan.com slan.com dlan.com rlan.com 4lan.com 3lan.com ekan.com epan.com eoan.com elzn.com | elsn.com elwn.com elqn.com elab.com elam.com elaj.com elah.com lan.com ean.com eln.com | ela.com lean.com ealn.com elna.com eelan.com ellan.com elaan.com elann.com |
Location
IP: 65.79.177.80
continent: NA, country: United States (USA), city: Scottsdale
Website value
rank in the traffic statistics: 873 627
There is not enough data to estimate website value.
Basic information
website build using CSS
code weight: 12.75 KB
text per all code ratio: 21 %
title: Homepage | Elan
description:
keywords:
encoding: UTF-8
language: en
Website code analysis
one word phrases repeated minimum three times
Phrase | Quantity |
---|---|
of | 3 |
Elan | 3 |
two word phrases repeated minimum three times
three word phrases repeated minimum three times
B tags
U tags
I tags
images
file name | alternative text |
---|---|
logo.gif | Elan |
banner-home_tcm10-22968.jpg | Advancing Science / Changing Lives |
bkt-arrow.gif | Featured Topics |
Tysabri-logo-wht_tcm10-23021.jpg | Marketed Drugs |
bkt-chart_tcm10-22975.jpg | Tysabri-logo-wht |
hp-placeholder_tcm10-28225.gif | Ongoing Clinical Trials |
headers
H1
H2
H3
H4
H5
H6
internal links
address | anchor text |
---|---|
/company/careers/ | Careers |
/company | Company |
/company/default.asp | About Us |
/company/vision.asp | Vision |
/company/management_team.asp | Management Team |
/company/board_of_directors.asp | Board of Directors |
/company/careers | Careers |
/company/careers/benefits_overview.asp | Benefits Overview |
/company/careers/us_benefits.asp | US Benefits |
/company/careers/job_search.asp | Job Search |
/company/contact_us.asp | Contact Us |
/therapies | Therapies |
/therapies/default.asp | Overview |
/therapies/disease_areas | Disease Areas |
/therapies/disease_areas/alzheimers_research.asp | Alzheimer's Disease |
/therapies/disease_areas/parkinsons_research.asp | Parkinson's Disease |
/therapies/disease_areas/multiple_sclerosis.asp | Multiple Sclerosis |
/therapies/disease_areas/crohns_disease.asp | Crohn's Disease |
/therapies/products | Products |
/therapies/products/default.asp | United States |
/therapies/products/european_union.asp | European Union |
/therapies/medical_education | Medical Education |
/therapies/medical_education/default.asp | Grant Guidelines |
/therapies/medical_education/grant_resources.asp | Grant Resources |
/therapies/medical_education/grant_application.asp | Grant Application |
/therapies/us_medical_information | US Medical Information |
/therapies/us_medical_information/medical_info_request_form.asp | Medical Information Request Form |
/rd | R&D |
/rd/default.asp | Overview |
/rd/research_areas | Research Areas |
/rd/research_areas/autoimmune_diseases.asp | Autoimmune diseases |
/rd/research_areas/neurodegenerative_diseases.asp | Neurodegenerative diseases |
/rd/drugs_in_development | Drugs in Development |
/rd/drugs_in_development/product_pipeline.asp | Product Pipeline |
/rd/clinical_trials | Clinical Trials |
/rd/clinical_trials/autoimmune_diseases.asp | Autoimmune diseases |
/rd/clinical_trials/neurodegenerative_diseases.asp | Neurodegenerative diseases |
/rd/resource_library.asp | Resource Library |
http://newsroom.elan.com | News & Events |
http://newsroom.elan.com/phoenix.zhtml?c=88326&p=irol-news&nyo=0 | Press Releases |
/news_events/news_features | News Features |
http://newsroom.elan.com/phoenix.zhtml?c=88326&p=irol-presentations | Events |
/corporate_governance | Corporate Governance |
/corporate_governance/committee_memberships.asp | Committee Memberships |
/corporate_governance/governance_guidelines.asp | Governance Guidelines |
/corporate_governance/committee_charters.asp | Committee Charters |
/corporate_governance/code_of_conduct.asp | Code of Conduct |
/corporate_governance/corporate_compliance.asp | Corporate Compliance |
/corporate_governance/comparison_of_corp_gov_practices.asp | Comparison of Elan Corporation, plc Corporate Governance Practices and US Companies Practices under NYSE Requirements |
http://ir.elan.com | Investor Relations |
http://ir.elan.com/phoenix.zhtml?c=88326&p=irol-irhome | Investor Overview |
http://ir.elan.com/phoenix.zhtml?c=88326&p=irol-news&nyo=0 | Financial News & Events |
http://ir.elan.com/phoenix.zhtml?c=88326&p=irol-stockquote | Stock Information |
http://ir.elan.com/phoenix.zhtml?c=88326&p=irol-analysts | Analyst Information |
http://ir.elan.com/phoenix.zhtml?c=88326&p=irol-reportsannual | Financials |
http://ir.elan.com/phoenix.zhtml?c=88326&p=irol-investorkit | Shareholder Services |
http://ir.elan.com/phoenix.zhtml?c=88326&p=irol-generalmeetings | General Meetings |
http://ir.elan.com/phoenix.zhtml?c=88326&p=irol-eventDetails&EventId=4155870 | Webcast |
/rd/drugs_in_development/product_pipeline.asp | View |
http://newsroom.elan.com/corporate.rss?c=88326&Rule=Cat=news|subcat=ALL | RSS Feeds |
http://newsroom.elan.com/phoenix.zhtml?c=88326&p=irol-newsArticle&ID=1617157&highlight= | More |
http://newsroom.elan.com/phoenix.zhtml?c=88326&p=irol-newsArticle&ID=1607676&highlight= | More |
http://newsroom.elan.com/phoenix.zhtml?c=88326&p=irol-newsArticle&ID=1607673&highlight= | More |
/privacy_policy.asp | Privacy Policy |
/terms_of_use.asp | Terms of Use |
/ | Home |
/sitemap.asp | Sitemap |
external links
address | anchor text |
---|---|
http://www.tysabri.com | Tysabri-logo-wht |
http://clinicaltrials.gov/ct2/results?term=elnd005 | More |
http://www.clinicaltrials.gov/ct2/show/NCT00707512?term=Tysabri&recr=Open&rank=7 | More |
http://www.facebook.com/pages/Elan-Corporation/147850095495 | |
http://twitter.com/elanplc |